ELUT · Elutia Inc.

$1.00 +0.06 (+6.16%)

Market Cap

$43.40M

44.29M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
C. Randal Mills	President and Chief Executive Officer	$600,000	—	$2,311,156	$1,617,373	—	$7,628	$4,536,157
Matthew Ferguson	Chief Financial Officer	$385,000	—	$902,500	$518,705	—	$3,427	$1,809,632
Michelle Williams	Chief Scientific Officer	$355,000	—	$722,000	$518,705	—	$1,779	$1,597,484

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
C. Randal Mills	President and Chief Executive Officer	$600,000	$149,111	$1,085,464	—	$210,889	$5,423	$2,050,887
Matthew Ferguson	Chief Financial Officer	$357,000	—	—	—	$160,650	$3,427	$521,077
Michelle Williams	Chief Scientific Officer	$330,000	—	—	—	$148,500	$7,470	$485,970

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ronald Lloyd	Prior President and Chief Executive Officer	$411,418	—	$394,625	$420,574	—	$1,064,173	$2,290,790
C. Randal Mills	President and Chief Executive Officer	$351,481	$210,889	—	$1,492,714	—	$4,597	$2,059,681
Thomas Englese	Prior Chief Commercial Officer	$396,003	—	$122,378	$93,953	—	$13,546	$625,880
Matthew Ferguson	Chief Financial Officer	$357,000	—	$114,676	$93,953	—	$3,655	$569,284

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ronald Lloyd	Prior President and Chief Executive Officer	$538,049	—	$236,665	$827,018	—	$7,925	$1,609,657
Matthew Ferguson	Chief Financial Officer	$350,162	—	$74,830	$261,498	—	$6,483	$692,973
Thomas Englese	Prior Chief Commercial Officer	$388,187	—	$54,488	$190,411	—	$7,922	$641,008

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ronald Lloyd	President and Chief Executive Officer	$490,477	—	$1,707,225	$1,600,903	$392,381	$7,707	$4,198,693
Jerome Riebman	Chief Medical Officer	$346,000	$65,000	$173,162	$455,928	$140,130	$1,559	$1,181,779
Darryl Roberts	Executive Vice President, Operations and Product Development	$309,000	—	$188,904	$441,065	$152,955	$6,282	$1,098,206

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ronald Lloyd	President and Chief Executive Officer	$465,283	—	—	$12,960	$203,940	$7,032	$689,215
Darryl Roberts	Executive Vice President, Operations and Product Development	$301,154	—	—	$8,400	$77,400	$4,200	$391,154

Executive changes

Person	Role	Change	Effective	Filed
W. Matthew Zuga	Board	Resigned	2025-10-08	2025-10-14
Maybelle Jordan	Board	Resigned	2025-10-08	2025-10-14
Guido Neels	Board of Directors	Appointed	2025-10-09	2025-10-14
Kevin Rakin	Class III director	Appointed	2023-06-08	2023-06-09
David Colpman	Class III director	Appointed	2023-06-08	2023-06-09
David Colpman	audit committee member	Appointed	2022-10-20	2022-10-24
David Colpman	Class III director	Appointed	2022-10-20	2022-10-24
Ronald Lloyd	member of the Board	Resigned	2022-06-21	2022-06-21
Ronald Lloyd	President and Chief Executive Officer	Resigned	2022-06-21	2022-06-21
C. Randal Mills	Interim President and Chief Executive Officer	Appointed	2022-06-21	2022-06-21

Key facts CIK 1708527 CUSIP 05479K106 13F (30d) 39 filings 38 filers Visit website Investor relations